Bidirectional Display v. Dermalog Jenetric: Biometric Sensor Patents Dismissed With Prejudice
Bidirectional Display, Inc. asserted two patents covering transparent optical TFT sensors for biometric capture against Dermalog Jenetric’s Livetouch product line in the Eastern District of Texas. After 551 days of litigation, the parties jointly stipulated to dismissal with prejudice under Rule 41, with each side bearing its own costs.
Biometric sensor patent dispute ends in mutual walk-away after 551 days
Bidirectional Display, Inc. filed suit on December 6, 2023 in the Eastern District of Texas against German biometrics manufacturer Dermalog Jenetric GmbH, asserting infringement of US10440223B2 and US10469694B2. Both patents relate to transparent optical TFT sensor technology used for capturing biometric data — the specific products accused included Dermalog’s Livetouch Duo, Livetouch Flipcase, Livetouch Quattro, Livetouch Quattro Compact Up, and associated transparent optical TFT sensors for biometrics.
The case closed on June 9, 2025 via a Joint Stipulation of Dismissal filed under Federal Rule of Civil Procedure 41(a)(1)(A)(ii), agreed to by both parties. The court accepted the stipulation and dismissed all claims with prejudice, meaning Bidirectional Display is permanently barred from asserting the same claims against Dermalog on these patents. Notably, each party was ordered to bear its own costs and attorneys’ fees, suggesting no prevailing-party determination was made.
At 551 days, the timeline is consistent with a case that progressed through substantive litigation stages — likely including claim construction preparation — before the parties reached resolution. The mutual cost-bearing arrangement and with-prejudice dismissal are hallmarks of a negotiated settlement, though the public record does not confirm specific settlement terms. What drove the resolution — whether a licensing agreement, a design-around, or a commercial compromise — remains undisclosed.
Filing to Dismissed with Prejudice in 551 days
551 days — above the median for patent cases resolved short of trial in E.D. Texas
Dismissed with prejudice: what the joint stipulation means for both parties
Rule 41(a)(1)(A)(ii) dismissal with prejudice explained
A stipulated dismissal under Rule 41(a)(1)(A)(ii) requires agreement from all parties and carries the same effect as a final adjudication on the merits when entered with prejudice. The court does not evaluate the underlying claims — it simply records the parties’ mutual agreement. Here, the court accepted the stipulation and formally extinguished all asserted claims and causes of action.
Stipulated — no merits rulingBidirectional Display permanently waives these specific claims
Dismissal with prejudice bars Bidirectional Display from relitigating the same patent claims against Dermalog Jenetric. Under claim preclusion principles, the patents US10440223B2 and US10469694B2 cannot be reasserted against this defendant for the accused Livetouch products. The patents themselves remain valid and can still be enforced against other third parties, preserving Bidirectional Display’s broader enforcement posture.
Patents survive; this defendant protectedDermalog secures permanent protection from this plaintiff
Dermalog Jenetric gains a full release from Bidirectional Display’s infringement claims on the asserted patents for its Livetouch product line. With prejudice dismissal provides a stronger shield than a without-prejudice exit — Dermalog cannot be sued again by this plaintiff on these same claims. The mutual cost-bearing order suggests neither side extracted a fee award, which is consistent with a negotiated commercial resolution.
Claim-barred — Livetouch line clearedBiometric sensor IP remains live against the broader market
The resolution leaves both patents in force and enforceable against other manufacturers of transparent optical TFT biometric sensors. Companies developing competing fingerprint capture hardware — particularly those using similar TFT display-integrated sensor architectures — should note that Bidirectional Display retains full enforcement rights. The Dermalog settlement, if any, likely reflects commercial terms not visible in the public record but does not limit future assertion.
Patents enforceable vs. third partiesFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Bidirectional Display, Inc. | Company | Biometric display technology IP holder — asserting US10440223B2 and US10469694B2Search in Eureka ↗ |
| Defendant | Dermalog Jenetric, Gmbh | Company | German biometrics manufacturer — maker of Livetouch transparent optical fingerprint sensorsSearch in Eureka ↗ |
| Plaintiff counsel | Douglas Chin | Attorney | Counsel for Bidirectional Display, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Ting Wei | Attorney | Counsel for Bidirectional Display, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Hsuanyeh Law Group, PC | Law Firm | Representing Bidirectional Display, Inc.Search in Eureka ↗ |
| Defendant counsel | Casey Allen Kniser | Attorney | Counsel for Dermalog Jenetric, GmbhSearch in Eureka ↗ |
| Defendant counsel | Melissa Richards Smith | Attorney | Counsel for Dermalog Jenetric, GmbhSearch in Eureka ↗ |
| Defendant law firm | Gillam & Smith, LLP | Law Firm | Representing Dermalog Jenetric, GmbhSearch in Eureka ↗ |
| Defendant law firm | Law Office of Casey A Kniser LLC | Law Firm | Representing Dermalog Jenetric, GmbhSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulation language — ‘the above-captioned case has been resolved’ — is a standard signal that a private agreement was reached before the court made any substantive ruling. The with-prejudice designation carries significant legal weight: it functions as a final judgment on the merits for preclusion purposes, permanently barring Bidirectional Display from reasserting these claims against Dermalog. The mutual cost allocation confirms the court made no prevailing-party finding, which is consistent with a consensual commercial exit rather than a litigation win for either side.
US10440223B2 & US10469694B2 — Transparent Optical TFT Biometric Sensors
US10440223B2 and US10469694B2 relate to transparent optical thin-film transistor (TFT) sensor technology engineered for biometric data capture — most directly fingerprint scanning integrated into or overlaid on display panels. The application numbers (US16/148452 and US16/214241) indicate both patents were filed in late 2018, placing their priority context in the early wave of under-display biometric integration. TFT-based optical sensing enables fingerprint capture through display glass without requiring a dedicated opaque sensor cutout, making it commercially significant for slim-form-factor and full-screen device design.
The strategic value of these patents lies in their potential application across a wide range of biometric hardware — from dedicated access-control scanners like Dermalog’s Livetouch line to consumer smartphones and enterprise identity verification terminals. As transparent under-display biometric sensing becomes standard in mobile and security hardware, patents covering foundational TFT sensor architectures carry growing licensing leverage. Bidirectional Display’s willingness to assert both patents simultaneously in E.D. Texas against a German OEM suggests an enforcement strategy targeting US market entrants rather than domestic manufacturers alone.
Should your team run an FTO against US10440223B2 and US10469694B2?
Any company developing, importing, or selling products that integrate transparent optical TFT sensors for biometric capture in the United States should treat these patents as active enforcement risk. The Dermalog litigation confirms Bidirectional Display is actively asserting both patents against hardware OEMs — including foreign manufacturers selling into the US market. Product categories at risk include under-display fingerprint scanners, biometric access terminals, TFT-integrated identity verification devices, and any display-sensor hybrid architecture using optical fingerprint detection.
PatSnap Eureka’s FTO Search Agent enables R&D and IP teams to map claim scope for US10440223B2 and US10469694B2 against your product architecture in minutes. Eureka surfaces related family members, citation clusters, and prior art candidates that may support design-around or invalidity arguments — giving your team actionable intelligence before product launch or US market entry, not after a demand letter arrives.
Run a freedom-to-operate analysis on US10440223B2 to assess your product’s exposure
Run FTO in Eureka →Similar biometric sensor patent cases in E.D. Texas and related courts
Cases involving transparent optical TFT and under-display biometric sensor patents litigated in the Eastern District of Texas and comparable venues.
What this case signals for the biometric sensor IP landscape
A with-prejudice exit after 551 days in E.D. Texas suggests a negotiated resolution — and signals active patent enforcement in the transparent TFT biometrics space.
E.D. Texas remains a high-pressure venue for biometric hardware defendants
The Eastern District of Texas continues to attract patent assertions against technology hardware companies, including foreign manufacturers like Dermalog. Defendants in this venue face significant pretrial motion costs and scheduling pressure that often accelerate settlement. Companies selling biometric capture products into the US market should factor E.D. Texas risk into their IP clearance strategy.
Transparent TFT sensor patents signal an emerging assertion cluster
The assertion of two structurally related patents covering transparent optical TFT biometric sensors suggests a deliberate enforcement portfolio strategy. Competitors and product teams developing integrated fingerprint-display sensor technology should map Bidirectional Display’s broader patent family to assess exposure beyond the two patents asserted in this case.
Bidirectional v Dermalog — key questions answered
The case was dismissed with prejudice on June 9, 2025, pursuant to a joint stipulation filed under Rule 41(a)(1)(A)(ii). Both parties agreed to the dismissal and each was ordered to bear its own costs and attorneys’ fees. The dismissal permanently bars Bidirectional Display from reasserting the same patent claims against Dermalog Jenetric.
Bidirectional Display asserted US10440223B2 and US10469694B2, both covering transparent optical TFT sensor technology for biometric data capture. The accused products included Dermalog’s Livetouch Duo, Livetouch Flipcase, Livetouch Quattro, and Livetouch Quattro Compact Up fingerprint scanners.
Dismissal with prejudice means Dermalog Jenetric cannot be sued again by Bidirectional Display on the same patent claims for the accused Livetouch products. It provides a permanent litigation shield equivalent in effect to a final judgment on the merits. The patents remain valid and enforceable against other parties, but Dermalog is protected from this plaintiff on these specific claims.
No. The dismissal was stipulated by the parties before any merits ruling. The court did not adjudicate infringement, invalidity, or claim construction. The verdict text explicitly states the case was ‘resolved’ by agreement, with the court simply accepting the stipulation — meaning the legal validity of both patents remains uncontested by this proceeding.
Bidirectional Display was represented by Hsuanyeh Law Group, PC, with attorneys Douglas Chin and Ting Wei. Dermalog Jenetric was represented by Gillam & Smith, LLP and the Law Office of Casey A. Kniser LLC, with attorneys Casey Allen Kniser and Melissa Richards Smith handling the defense.
PatSnap Eureka searches patents and litigation data to answer instantly.